Good morning, Kelly
-
Total Contacts
-
Committed
-
Warm Leads
-
Priority A
📊 Pipeline
🔥 Top Priority Contacts
What needs to happen
📝 Recent Memory
🔭 Competitor Radar
🚀 My Projects
⭐ Recent Wins
Open Loops
Every tab open in your head, in one place. Clear them one by one.
| Name | Company | Status | Category | |
|---|---|---|---|---|
| Loading contacts... | ||||
Loading memory files...
Knowledge Base
Articles, videos, papers, and resources. Tell Kip "save this: [URL]" to add anything.
Loading knowledge base...
🎯 Kelly's Big 3 This Week
📅 Upcoming Deadlines
🦉 Kip's Working On
✅ Done Today
| To | Subject | Status | Sent |
|---|---|---|---|
| Loading outreach data... | |||
🎯 This Week's Big 3
✅ Bloomed — Ideas that became real
What Does "Early Detection" Actually Look Like?
Invisible to everything else
No blood. No radiation.
10x larger tumor needed
$950/test. 17% Stage I.
Current "early" detection
~30 cell divisions. Radiation.
By the time current technology finds cancer, you already have a
billion cells
growing inside you.
How It Works: Wavelength-Specific Biophoton Signatures
Detection Threshold Comparison
HelioFlux (Biophotonics)
5-10M cells
Non-invasive. No blood draw. No radiation. 90% accuracy.
Liquid Biopsy (Galleri/cfDNA)
50-100M cells
$950/test. Only 17% sensitivity at Stage I. Requires blood draw.
Traditional Imaging (MRI/CT)
1B+ cells
Tumor must be 5-10mm. Ionizing radiation (CT). Expensive. Current standard of care.
"Early" Detection (Current Standard)
~1B cells
Even "early" detection by today's methods still requires ~1 billion cells (1cm tumor, ~30 cell divisions).
90-92%
HelioFlux Accuracy
Two independent methods: SPD analysis (90%, Cancers 2020) and wavelength-specific filters (92%, BBR 2018). 100% of cancer cases correctly identified.
Sources: Cancers 12(4), 2020 + Biochem Biophys Rep 13, 2018
17%
Galleri Stage I Sensitivity
Misses 83 out of 100 early-stage cancers. Overall sensitivity across all stages: 51.5% (coin flip)
Source: GRAIL clinical data, 2025
Published Research
Cancers, 2020 — Cancer Detection
"Ultraweak Photon Emissions as a Non-Invasive, Early-Malignancy Detection Tool"
13 cell lines tested. 90% discriminant accuracy. Tumors detectable 24h post-injection in mice.
90% accuracy
13 cell lines
in vitro + in vivo
24h detection
Biochemistry and Biophysics Reports, 2018 — Wavelength-Specific Detection
"Biophotonic markers of malignancy: Discriminating cancers using wavelength-specific biophotons"
Wavelength filters (420nm, 620nm, 950nm) classify cancer vs non-cancer. 92% accuracy. 100% of cancer cases correctly identified.
92% accuracy
100% cancer detection
wavelength-specific
UV/IR ratio
iScience (Cell Press), 2025 — Brain Monitoring
"Exploring ultraweak photon emissions as optical markers of brain activity"
20 human subjects. First photoencephalography demonstration. Cross-validated with EEG.
human validation
Cell Press
EEG cross-validated
platform tech
Investor Quick-Reference Numbers
5-10M
HelioFlux detection
50-100M
Liquid biopsy
1B+
Traditional imaging
90-92%
HelioFlux accuracy
17%
Galleri Stage I
51.5%
Galleri all stages
Platform Technology Applications
🔬
Cancer Detection
90% accuracy preclinical. 13 cell lines. In vitro + in vivo.
VALIDATED (Cancers 2020)
🧠
Brain State Monitoring
20 human subjects. Photoencephalography. EEG cross-validated.
VALIDATED (iScience 2025)
💊
Chemo Brain Detection
Neurotoxic insult monitoring. Paper explicitly validates application.
IN RESEARCH
🧬
Cell Reprogramming
Biophysical signals to reprogram disease states. Phase 3 treatment vision.
PLANNED
Featured Coverage
Scientific American
June 2025
Your Brain Is Glowing, and Scientists Can't Figure Out Why
Researchers have measured the brain's faint glow for the first time, hinting at a potential role of "biophotons" in cognition. Covers Nirosha's iScience 2025 paper.
"The very first finding is that photons are coming out of the head — full stop. It's independent, it's not spurious, it's not random."
Dr. Nirosha Murugan, quoted in Scientific American
📰
Radiolab / NPR
September 2025
The Spark of Life — "Are We... Glowing?"
Full episode featuring Nirosha Murugan. From the 1920s onion root experiment to detecting light from the human brain. Links to biophoton cancer diagnosis research.
"Plants give off light. Shrimp give off light. Literally everything that is alive emits light. And what about us humans?"
Dr. Nirosha Murugan, on Radiolab
🎙
CTV News
Television
Biophoton Cancer Detection Research Feature
Canada's largest private broadcaster. Coverage of biophoton detection technology and its potential for non-invasive cancer screening.
📺
LA Business Journal
Print + Online
HelioFlux Company Profile
Los Angeles business press coverage of HelioFlux and biophotonic cancer detection technology.
📰
4+
Major Outlets
Scientific American, Radiolab/NPR, CTV News, LA Business Journal
3
Peer-Reviewed Papers
BBR 2018, Cancers 2020, iScience/Cell Press 2025
Quotable Highlights for Investors
"Photons are coming out of the head — full stop. It's independent, it's not spurious, it's not random."
Dr. Nirosha Murugan — Scientific American, June 2025
"This is a very intriguing and potentially groundbreaking approach [for measuring brain activity]."
Dr. Michael Gramlich, Biophysicist, Auburn University — Scientific American
"Plants give off light. Shrimp give off light. Literally everything that is alive emits light."
Dr. Nirosha Murugan — Radiolab "The Spark of Life," September 2025
Credibility Stack
🏫
Canada Research Chair
Nirosha holds CRC in Bioelectricity
💻
NVIDIA Inception
Accepted October 2024
💰
$1.3M+ Research Grants
Through Nirosha's lab
🏆
Forbes Midas List Advisor
Jim Armstrong, Board Member
-
Done
-
In Progress
-
Blocked
-
Ideas
Loading OpenClaw ideas...
Job Tracker
Applications, gigs, and what still needs doing
Agenda
Upcoming meetings and deadlines
Upcoming Meetings
Deadlines & Action Items
Wins Board
Momentum log — every win counts
Investor Radar
Warm leads and active conversations going stale — sorted by priority
Meetings
Upcoming calls — prep notes, talking points, questions
The Notebook
Questions you're living with. Things you want to figure out. Newton called these Quaestiones. Da Vinci filled notebooks with them.